You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 136 No. 12, December 1976 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Streptozocin-Treated Verner-Morrison Syndrome

Plasma Vasoactive Intestinal Peptide and Tumor Responses

Robert F. Gagel, MD; Mary E. Costanza, MD; Ronald A. DeLellis, MD; Richard A. Norton, MD; Stephen R. Bloom, MA, MB; Harry H. Miller, MD; Angelo Ucci, MD; Larry Nathanson, MD

Arch Intern Med. 1976;136(12):1429-1435.


Abstract



A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the pancreas (Verner-Morrison syndrome) was found to have an elevated vasoactive intestinal peptide (VIP) concentration in the plasma as well as in the tumor. Treatment with streptozocin resulted in a dramatic subjective and objective tumor response in this patient. Plasma VIP concentration fell into the normal range after four courses of treatment, diarrhea ceased after the third course of therapy, and measurable tumor mass markedly decreased during that same period of time. The patient remains in clinical remission with no evidence of tumor regrowth 18 months after the beginning of treatment. In this patient, plasma VIP measurements were an excellent marker of tumor activity and correlated well with objective disease measurements and clinical response.

(Arch Intern Med 136:1429-1435, 1976)



Author Affiliations



From the Departments of Medicine (Drs Gagel, Costanza, Norton, and Nathanson), Pathology (Drs DeLellis and Ucci), and Surgery (Dr Miller), Tufts-New England Medical Center, Boston, and the Royal Postgraduate Medical School, Hammersmith Hospital, London (Dr Bloom).


Footnotes



Received for publication Feb 9, 1976; accepted May 25.

Reprint requests to Department of Medicine, Tufts-New England Medical Center Hospital, 171 Harrison Ave, Boston, MA 02111 (Dr Costanza).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effective Streptozocin Therapy for Metastatic Pancreatic Polypeptide Apudoma
Friesen et al.
Arch Surg 1981;116:1090-1092.
ABSTRACT  

Trifluoperazine Reversal of Secretory Diarrhea in Pancreatic Cholera
DONOWITZ et al.
ANN INTERN MED 1980;93:284-285.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.